Heidelberg Pharma deepens ADC alliance with Huadong
Why it matters: The companies plan to combine their technologies and development capabilities, including Heidelberg Pharma’s proprietary ATAC…
Actimed retrieves ALS drug after Faraday collapse
Why it matters: Actimed had previously retained S-oxprenolol only for ALS. Bringing the remaining rights back in-house broadens…
Austria advances gambling law to EU review in next licensing step
The proposed gambling regulations would allow 13 casino licences as well as a self-exclusion register and new mandated…
AstraZeneca taps Pathos for breast cancer degrader
Why it matters: The deal allows AstraZeneca to retain shared rights to a next-generation estrogen receptor therapy while…
Neurimmune turns future royalties into $425m pipeline cash
Why it matters: The deal allows Neurimmune to raise substantial non-dilutive funding without issuing shares. Since the responsibility…
Temu partners with Start:up Slovenia to help Slovenian businesses reach shoppers across Europe
The partnership gives Slovenian businesses a route to Temu’s EU-wide customer base, cross-border delivery, and guidance on selling…
AstraZeneca reunites with Dizal in $1.5bn lung cancer deal
Why it matters: The deal gives British-Swedish AstraZeneca a potential companion to its blockbuster EGFR inhibitor Tagrisso, extending…
European Commission proposes strict curbs on imports from illegal West Bank settlements | Ukraine news
A leaked EU internal memo outlines tougher enforcement to block products from illegal settlements, prompting debate among member…
Genentech signs $515m breast cancer deal with Astex
By the numbers: The R&D deal with Roche’s Genentech is worth more than $515 million plus royalties and…
AstraZeneca returns to CSPC with $1.77bn kidney deal
Why it matters: The agreement adds to a fast-growing relationship between the Cambridge-headquartered pharma and CSPC, and underlines…
ICAC Commissioner attends first IAACA European regional anti-corruption conference in Hungary
BUDAPEST, Hungary, July 2, 2026 /PRNewswire/ — ICAC Commissioner, Mr Woo Ying-ming, in his capacity of President of…
AlzeCure licenses Alzheimer’s asset to QuantumCell in $2.2bn deal
Why it matters: The agreement gives AlzeCure another non-dilutive financing route for its CNS pipeline, shortly after the…